NEW YORK (GenomeWeb) – Thermo Fisher Scientific and DuPont Nutrition & Health have announced three new distribution agreements for the DuPont BAX System Q7, covering the regions of Western Europe, Australia and New Zealand, and Canada.
Under the terms of the agreement for Western Europe, Thermo Fisher will retain exclusive rights to distribute the PCR-based food safety testing platform for three more years. Under separate agreements, Thermo Fisher will also continue to supply the platform in Australia and New Zealand on an exclusive basis and in Canada on a non-exclusive basis.
Financial and other details of the agreements were not disclosed.
"Thermo Fisher's office-based and in-field specialists have a long history of supporting the BAX System Q7, and the technical expertise and experience they can provide our customers in these regions is unparalleled," George McVay, diagnostics global business and integrated operations leader at DuPont Nutrition & Health, said in a statement. "We look forward to continuing our current arrangement to serve and support our food manufacturing and contract laboratory customers."
The deals renew a 14-year partnership between the partners in those regions. As reported by GenomeWeb, VWR holds exclusive distribution rights to the BAX System Q7 in the US.